Boswellia is well tolerated in trials, and 1 of the most searched questions about it concerns the liver. The 90-day data are reassuring but limited.
This article covers what people actually report, what the trial safety measurements showed, the interactions worth taking seriously, and the 5 groups who should not start it without asking a clinician first.
Quick Answer: Is Boswellia Safe?
For most adults, yes. In a 90-day double-blind trial of 75 knee osteoarthritis patients, blood, urine and biochemical safety parameters were essentially unchanged versus placebo. Mild digestive upset is the common complaint. Avoid it in pregnancy, and ask first if you take anticoagulants or immune-modifying medication.
Key Takeaways
- In the 90-day trial, all safety parameters were essentially unchanged.
- Mild digestive upset is the 1 complaint reported at any dose.
- Take it with 1 meal to reduce reflux and nausea.
- Avoid it in pregnancy, 1 caution based on traditional emmenagogue use.
- At least 3 medication groups warrant a clinician conversation first.
Related Products
What People Actually Report
Boswellia's side effects are mild, dose related and mostly digestive. They are also the reason people stop in week 1, before a 4-week trial has had a chance to answer anything useful.
- Nausea or reflux: Most common on an empty stomach.
- Loose stools: Usually at the higher resin amounts.
- Stomach discomfort: Often solved by taking it with a meal.
- Skin rash: Uncommon, and a reason to stop rather than push on.
Most of those resolve by moving the capsule to a meal and dropping back 1 dose step. The context for the resin itself is in our boswellia guide.
What the Trial Safety Data Showed
Unusually for a botanical, there is a proper safety dataset. The 90-day knee osteoarthritis trial measured a battery of biochemical parameters in serum, haematological parameters and urine analysis across all 3 groups, and found them essentially unchanged in the treatment arms.[1]A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee — Arthritis Research and Therapy View source
| What was measured | Result over 90 days |
|---|---|
| Serum biochemistry | Essentially unchanged versus placebo |
| Haematological parameters | Essentially unchanged |
| Urine analysis | Essentially unchanged |
| Dropouts for adverse events | 5 of 75 did not complete, across all arms |
That is 90 days in 75 people, which is reassuring rather than definitive. It does not tell you what 3 years of daily use does, and nobody has published that.
Pooled reviews reach the same conclusion from a different direction: across 69 studies of 20 supplements, there were no differences from placebo on safety outcomes except for 1 compound, diacerein.[2]Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis — British Journal of Sports Medicine View source
The Liver Question
Boswellia liver damage is a frequently searched phrase, and it deserves a straight answer rather than either reassurance or alarm. There is no established pattern of liver injury from boswellia in the clinical trial literature, and the 90-day trial found serum biochemistry unchanged.
- Trial data: No signal across 90 days in 75 patients.
- Pooled reviews: Safety generally reported as comparable to placebo.
- The real caveat: Trials are short and enrol healthy livers.
- If you have liver disease: Ask before starting, as with any supplement.
Anyone taking several supplements at once should also remember that attribution gets impossible in a stack of 5 products. A single-ingredient bottle makes any reaction traceable.
The pharmacokinetic and clinical literature on the species has been reviewed in full, which is the better starting point than a forum thread.[3]Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data — Clinical Pharmacokinetics View source
Interactions Worth Taking Seriously
Three medication groups justify a conversation before starting, and the reasoning is mechanistic rather than a list of theoretical worries.
| Medication | Why it matters | What to do |
|---|---|---|
| Anticoagulants and antiplatelets | Herbal anti-inflammatories can affect bleeding risk | Ask before starting |
| Immune-modifying drugs | Boswellic acids act on inflammatory signalling | Clinician conversation first |
| NSAIDs taken daily | Different enzymes, but overlapping purpose | Review whether both are needed |
| Any prescribed arthritis therapy | Boswellia is symptomatic support only | Never stop treatment to try it |
Dose decisions interact with all of this, which is why the amount and the medication list belong in the same conversation. The dose ladder is in the dose ladder and food rule.
Who Should Not Take Boswellia
The list is short because most internet warnings do not survive checking. These 5 do, on either traditional-use or mechanistic grounds.
Talk to a clinician before starting boswellia if you
- Are pregnant, trying to conceive, or breastfeeding
- Take warfarin, apixaban, clopidogrel or another blood thinner
- Take immunosuppressant or biologic therapy
- Have liver disease or unexplained abnormal liver tests
- Are due to have surgery within the next 2 weeks
- Are giving it to a child or teenager
Pregnancy is the firmest of those, on traditional emmenagogue grounds rather than trial evidence. A single-ingredient product such as our boswellia capsules at least makes the ingredient list easy to hand to a pharmacist.
What to Do If It Disagrees With You
Most reactions are mild and fixable, and the order of steps matters. Stopping outright on day 3 throws away information you could have kept.
- Step 1: Move it to the middle of a meal.
- Step 2: Drop to half the dose for 1 week.
- Step 3: Split the daily amount across 2 meals.
- Step 4: Stop if symptoms persist beyond 2 weeks.
- Always: Treat rash, swelling or breathing difficulty as urgent.
Frequently Asked Questions
Which boswellia side effects are dose-related? +
Mild digestive complaints dominate: nausea, reflux, stomach discomfort and loose stools, mostly at higher doses or on an empty stomach. In a 90-day trial of 75 patients, blood and urine safety parameters were essentially unchanged versus placebo.
Does boswellia cause liver damage? +
No established pattern of liver injury appears in the trial literature, and the 90-day study found serum biochemistry unchanged. The honest limit is that trials run 12 weeks and enrol healthy livers, so anyone with liver disease should ask first.
Can boswellia raise liver enzymes? +
The 90-day knee trial included urine analysis and found it essentially unchanged across the treatment arms. That covers 3 months in 75 people with normal kidneys, which is not the same as safety data for existing kidney disease.
Who should not take boswellia? +
Anyone pregnant or breastfeeding, anyone on anticoagulants or immune-modifying therapy, people with liver disease, and anyone within 2 weeks of surgery. That is 5 groups, and each has a mechanistic or traditional-use reason behind it.
Can boswellia thin your blood? +
Herbal anti-inflammatories are commonly flagged for bleeding risk, and boswellia acts on inflammatory signalling pathways. Not 1 large trial has measured clotting outcomes, so the conservative approach with any anticoagulant is to ask before starting.
Does boswellia upset your stomach? +
It can, especially on an empty stomach. Taking it with 1 meal containing fat both improves absorption and reduces reflux. Dropping to half the dose for a week resolves most remaining complaints without abandoning the trial.
Is boswellia safe in pregnancy? +
No. Traditional use as an emmenagogue is reason enough to avoid it, and no trial has tested it in pregnancy. The same applies while breastfeeding, where there are 0 safety studies to draw on.
Can I take boswellia before surgery? +
Stop at least 2 weeks beforehand and tell your surgical team, as with most anti-inflammatory supplements. Perioperative bleeding risk is the reason, and the decision belongs with the team doing the procedure.
Does boswellia interact with NSAIDs? +
They act on different enzymes, boswellia on 5-lipoxygenase and NSAIDs mainly on cyclooxygenase, so they are not duplicates. The practical question is whether you still need both, which is worth reviewing after a 4-week trial.
Is boswellia safe for long-term daily use? +
The longest good trial ran 90 days. Beyond that, evidence thins, and a 69-study review found no supplement with clinically important long-term pain effects, which argues for planned reviews rather than indefinite use.
Can children take boswellia? +
The trials enrolled adults, so there is no dosing or safety basis for children. Any use in someone under 18 should be a clinician's decision rather than a scaled-down adult dose.
Related Reading
- The Benefits Set Against These Cautions
- What the Arthritis Trials Found
- Why 5-LOX Matters for Interactions
- Does Extract Strength Change Tolerance?
Related Products
